Search results
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 4 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 3 days ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 4 days agoThe French drug giant Sanofi is taking a minority stake in Novavax and entering into a licensing...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 4 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 4 days agoNovavax (NASDAQ:NVAX) shares skyrocketed more than 120% in premarket trading Friday, driven by the...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
CBS 47 Fresno· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing ...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 4 days agoShares of Novavax (NVAX 98.66%) are up 12% as of midday Friday following the release of the...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 4 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven by the company’s...
Novavax Shares Surge Over 130% After $1.4 Billion Covid Shot Deal With Sanofi
Forbes· 4 days agoShares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4...
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 4 days agoVaccine-maker Novavax announced a $1.2 billion licensing partnership with French pharmaceutical...